Introduction
Oral squamous cell carcinoma (OSCC) is the most common type of head and neck cancer globally with an annual incidence of around 275 000 [1] . It is more prevalent in men, and prevalence is increasing [2] . In particular, tongue cancer incidence has been rising in various parts of the world in recent years, and especially in patients under 45 [1, 3] . Strong risk factors include alcohol and tobacco.
Western 5-year survival rates for oral cavity cancer are around 60% [3] [4] [5] . Five-year disease-specific survival (DSS) of OSCC of the mobile tongue decreases as the stage increases. In Finland, 5-year DSS is 87% for stage I carcinomas, but 51% for stage IV. Interestingly, recurrence occurred in 22-34% of patients, slightly varying by stage [6] .
However, the TNM classification does not fully account for OSCC patients' outcomes [7] ; tumours with the same TNM stage can exhibit different behaviours, treatment responses, and prognoses [8] . Different molecules and pathways have been linked with OSCC cancer behaviours, such as the VEGF-Flt-1 pathway with invasion [9] , kallikreinrelated peptidase with metastatic capacity [10] , and glutathione-peroxidase-I overexpression with poor prognosis [11] . None of these are yet in clinical use.
Nano Ultra-Performance Liquid Chromatography Label-Free UltraDefinition Mass Spectrometry (nUPLC-UDMS E ) is a highly sensitive form of mass spectrometry (MS), capable of quantifying hundreds-tothousands of proteins in solution. nUPLC-UDMS E discovery-driven analysis offers a unique avenue to discover proteins and pathways that are previously not known to be altered in OSCC. Previously, studies using non-pooled paired healthy and OSCC tissue samples for direct comparison with MS have used a gel-based matrix to register the differences between the cases and controls after which protein spots are identified using MS [12] [13] [14] . However, shotgun proteomics, as done here, and the electrophoresis approaches have different scopes and limitations. Electrophoresis mainly homes in on critical alterations such as isoform differences, and post-translational modifications, whereas shotgun approaches aim for a broad overview of proteomic changes, including those with smaller abundances, and allows for novel protein discovery. These two approaches can be complementary [15] . The primary aim of this study was to identify and quantify the differences between healthy tissue and OSCC using nUPLC-UDMS E proteomics. In particular, we aimed to discover novel proteins with significantly different expression in OSCC compared with controls, along with differences in protein expression between high-and lowgrade tumours. This will facilitate future research to assess whether these proteins can be used as potential new prognostic or predictive biomarkers, for example predicting different clinical behaviours of OSCCs. Additionally, the discovery of proteins involved can help in identifying important pathways in OSCC pathogenesis and thus potential therapeutic targets.
Materials and methods
Briefly, tissues of primary OSCC of the mobile tongue, and paired healthy tongue epithelium were taken preoperatively and immediately frozen. At the time of analysis, the tissues were thawed and lysed, and protein extraction was performed. The proteins were trypsin digested, and the tryptic peptide mixture was analysed using mass spectrometry (nUPLC-UDMS E ), to identify proteins differing between OSCC and paired healthy epithelium. Statistical classification and separation techniques were performed to ensure clear differences between OSCC and healthy tissue. Pathway analysis using two methods were performed to assess altered pathways within OSCC to gain greater understanding. We additionally performed a comparison between stage I and stage IVa OSCC. Selected proteins that have previously been found to be altered in serum of OSCC [16, 17] and that we also found to be altered in the tissue were validated with immunohistochemistry (IHC 
Results

Proteomics of OSCC and healthy tongue tissue
Of 829 proteins with two or more unique peptides that were quantified, 257 proteins were statistically significant (Supplementary Table 2 ).
The majority of proteins were present in both the cancer and control tissue in differing amounts, but one protein (alpha-taxilin) was absent Label Free Ultra-definition mass spectrometry was performed on OSCC of the tongue and paired healthy controls. Anova analysis was performed on these, with a p-value cut-off of 0.05. For group classification, PCA, OPLS-DA and Hierarchical Clustering Analysis were used, and significant proteins were identified using OPLS-DA analysis. Using String PPI and IPA, pathways altered in OSCC were identified. Furthermore, stage IVa vs stage I OSCC protein expressions were compared. Validation was performed on selected proteins, to confirm their presence is consistent in tumour samples, and to identify which cells within the tumour express these proteins. These proteins are known to be significantly altered in OSCC serum compared to controls in a previous study [16] . (Fig. 2d) .
PCA was used to determine and visualise the principal axes of protein abundance variation between the two groups. This showed a complete separation between cancer and healthy tissue when using all 829 proteins, with the separation becoming even clearer when just the statistically significant proteins were included ( Fig. 2a and b) .
OPLS-DA was used to model the differences between the two groups. One OSCC tissue sample from patient number two was removed as it lay beyond the 95% confidence range. An S-plot was generated from the data (Fig. 2c) . Proteins exceeding the p(corr) cut-off value of ± 0.7 were considered to be significant ( 
Comparison between proteomic signatures of the stage I and stage IVa OSCC
The proteomic differences between stage I and stage IVa OSCC were performed using the same methods as for the tumours versus controls. There were 17 protein differences with Anova p < 0.05, which can be seen in Table 2 . The most upregulated of these being KIAA1217 (FC 4.94) and NDRG1 (FC 4.12). The most downregulated proteins were cytochrome b-c1 complex (FC -2.64) and heat shock protein HSP 90 alpha (FC -2.61). There was some overlap on PCA when using all the 827 proteins ( Fig. 3a) , however upon using the statistically significant proteins, there was a clear separation between stage I and stage IVa (Fig. 3b) .
Immunohistochemistry of carbonic anhydrase 1 (CA1), S100A7, and neutrophil defensin 1 (DEFA1)
CA1, S100A7 and DEFA1 were proteins, which were also found to be altered in the serum of OSCC patients [17] , as well being some of the most differentiating tissue proteins after OPLS-DA modelling. IHC of these proteins was performed on an independent tissue microarray (TMA) block cohort of OSCCs, and separate healthy tissue samples from OSCC patients. This confirmed stronger staining in OSCC than healthy epithelium. S100A7 showed heterogeneous cytoplasmic, membranous and nuclear positivity in tumour tissue, whereas in the controls positivity was present in only the epithelial keratin layer. DEFA1 immunopositivity was strong in tumour cells, both cytoplasm and nuclei, and additional positivity was detected in inflammatory cells surrounding the cancer tissue. In the control tissue, positivity was cytoplasmic throughout the epithelium, with more intense, and additional membranous positivity in the basal cell layers. CA1 showed moderate cytoplasmic positivity throughout the tumour tissue, and also membranous positivity in some tumours. Inflammatory cells also had immunopositivity. In the controls, positivity was localised to the epithelium, and was stronger in the basal layer. Fig. 4 shows examples of, and the proportions of mild, moderate and strong tumour staining positivity by intensity in the tumour.
Pathway analysis of OSCC tissue
We performed two analytical methods to determine the important networks and pathways altered in OSCC compared to healthy tissue. String protein-protein interactions (PPI) shows direct connections linking the S-plot proteins as shown in Fig. 5 , where there are clusters of cytoskeletal proteins such as myosin and tropomyosin chains, and clusters of nuclear proteins such as ALYREF (THO complex subunit 4), NAP1L1 (nucleosome assembly protein 1-like 1), PABPN1 (Polyadenylate-binding protein 2), DNAJC8 (dnaJ homolog subfamily C member 8). Ingenuity pathway analysis (IPA) shows the significantly altered networks in OSCC, i.e. those enriched in the S-plot proteins. IPA includes proteins via which these proteins are known to interact, thus filling in the gaps of the proteins that may not have been detected. The top networks enriched were 1: 'Cellular movement, haematological system development and function, immune cell trafficking', 2: 'Hereditary disorder, organismal injury and abnormalities, skeletal and muscle disorders, 3: 'Cell-to-cell signalling and interaction, cellular movement, nervous system development and function', 4: 'Infectious diseases, dermatological diseases and condition, organismal injury and abnormalities'. These are all significant and highly enriched networks, with network scores between 31 and 56, and enriched with 16 to 25 proteins. This method verifies the s-plot proteins' significance on a pathway level. The overlay of both network analysis methods further shows that there is crossover between all of these OSCC networks. For example, a connection between ALYREF (THO complex subunit 4) and DNAJC8 connects Networks 2 and 3, connections between stathmin 1 (STMN1) and tropomyosins (connecting Networks 1 and 2).
IPA also identified significant canonical pathways enriched with the p < 0.05 proteins (Supplementary Fig. 1 ). The top canonical pathways include calcium signalling, regulation of actin-based motility by Rho, actin cytoskeleton signalling and tight junction signalling.
Discussion
OSCC is often detected late with the consequences of poor survival. Treatment can also be functionally impairing. OSCC incidence is increasing and has a high recurrence rate [6] . The disease course is unpredictable, without any established biomarkers for prognostication or prediction. Such biomarkers are needed urgently. Additionally, it is imperative to uncover the pathobiology of OSCC at the tissue level to identify potential treatment targets.
Proteomic comparisons nUPLC-UDMS
E discovery-driven analysis offers a unique avenue to discover proteins and pathways that are previously not known to be altered in OSCC. Some similar patterns were found, when compared to previous proteomic studies [12] [13] [14] such as proteasome activator, peripherin, keratin (KRT) 17 and cofilin-1 upregulation [12] , downregulation of cytoskeletal proteins such as myosin light and heavy chains, tropomyosins (except upregulation of tropomyosin 4) [14] , and upregulation of matrix-metalloproteinase 9, S100A7, thymosin beta 10, tenascin C, calreticulin, and downregulation of lumican [18] . The 257 proteins significantly differing between OSCC and healthy tissue were further modelled using OPLS-DA, which classifies samples based on their protein signature and shows their separation and similarities in a way that is difficult to obtain using other means. Among the S-plot proteins generated from this analysis (Table 1) , there were 19 proteins, which to our knowledge are not previously known to be upregulated in OSCC, although some have been found in other cancers. These could be further studied as potential biomarkers. Those with the greatest abundance include prosaposin (PSAP) and Acidic leucine-rich nuclear phosphoprotein 32 family member B (ANP32B). The rest are found in Table 1 , along with p-value, fold change and AUROC information. ANP32B, with an AUROC of 0.939, is upregulated in colorectal carcinoma [19] and breast cancer, and knockdown in cancer cells induced G1 arrest [20] . Alpha-taxilin, with an AUROC of 1, is interesting through its absence in 5 of the 7 control samples. It has not been found in OSCC before, but in colorectal cancer its overexpression correlates with proliferation activity [21] , and is associated with metastatic and invasive potential of renal cell carcinoma [22] . These may be of interest for future research in OSCC. The two most upregulated proteins in stage IVa tumours, compared with stage I (Table 2) , were KIAA1217 and protein NDRG1, both linked with proto-oncogenes. Little is known of KIAA1217 in cancer. It was recently discovered as a novel fusion partner gene with the RET protooncogene in one case of lung adenocarcinoma, whereby the fusion of RET with KIAA1217 led to activation of downstream signalling molecules: STAT3, AKT, and ERK. This was linked with increased tumour cell invasion in the study [23] . However, there are no further studies or reports of this protein in carcinoma progression. Also known as n-myc downstream-regulator protein 1, NDRG1 is a metastasis suppressor gene that inhibits the NF-κB (nuclear factor-κB) pathway, thus inhibiting functions such as angiogenesis, proliferation, migration and invasion [24] . Its over-expression in OSCC has been linked in one study with long-term specific survival [25] . As the n numbers were small in our study, with three stage I and four stage IVa tumours, more investigation will be required to validate these results, especially with regards to the relatively unknown KIAA1217.
Three of the most significantly different proteins in the tissue proteomic analysis found on S-plot, that were also altered in serum OSCC compared to healthy [16] , were S100A7, DEFA1 and CA1.
CA1 has been discovered in other tumours, such as breast cancer and small cell lung cancer (SCLC). In breast cancer, CA1 blockade with siRNA in tumour cell lines stimulated apoptosis and cell migration, suggesting that it may have an important role in mediating these processes [26] . Its upregulation in SCLC serum compared with benign lung disease patients, and healthy controls, caused it to be suggested as a potential biomarker [27] . Carbonic anhydrases are downstream proteins of hypoxia-inducible factor, which becomes stabilised under hypoxic conditions, for example in tumour cells, and mediates the transcription of proteins involved in glycolysis, angiogenesis and pH regulation [28] . Levels of CA1 in our study had a fold change of 3.4 in the tissue, compared with healthy samples. In the tumour tissue, CA1 immunopositivity was stronger than in controls. It has recently shown a similar upregulation in OSCC tissue using electrophoresis-based proteomics [14] . Other carbonic anhydrase family members IX and XII have been extensively investigated in cancers, including CAIX in OSCC [29] . There are some promising carbonic anhydrase inhibitors; phase 1 trials are currently underway for the selective carbonic anhydrase IX inhibitor SLC-0111 in patients with advanced solid tumours [30] .
DEFA1 is produced by epithelial cells and neutrophils, and has been identified in multiple carcinomas, including overexpression in human oral tongue OSCC [31] . Another previous tongue OSCC study, which showed an association between neutrophil invasion and lymph node metastasis, higher stage, and increased rate of tumour recurrence, also demonstrated strong DEFA1 immunopositivity in neutrophils within tumour tissue but not in the surrounding tissue [32] . That study showed high protein fold changes in OSCC compared with control, similar to our fold change of 19.8 found with MS. In our study, IHC demonstrated DEFA1 immunopositivity in both inflammatory cells and tumour cells. Mild to moderate positivity was also seen in normal epithelia, however no particular staining of inflammatory cells in the control samples. S100 proteins are known to be involved in tumours; some members as tumour suppressors and others act as tumour promotors [33] . S100A7 is a key player in tumour migration, invasion and induction of epithelial-mesenchymal transition, among others in OSCC [34] . In our study, S100A7 expression was detected in all tumour samples. Interestingly, there was heterogeneity in positivity in the tumour tissue, shown in Fig. 4 . In head and neck squamous cell carcinoma (HNSCC), nuclear S100A7 has been associated with reduced disease-free survival [35] . Members of the S100 protein family are differently expressed in various cancers -expression patterns depend on the tumour, its subtype and stage [33] . In HNSCC, the majority of the S100 proteins are downregulated whereas in most other cancers they tend to be upregulated (33) , contrasting with our findings of other S100 proteins S100A2, 7, 7A, 12 being significantly upregulated in the OSCCs, which could be the particular pattern in tongue cancer. Clinical trials are ongoing for targeting other S100 proteins, like S100B in melanoma [36] , confirming that there is a possibility to target these proteins therapeutically.
Pathway analysis
One aim of our study was to gain insight into the pathways and networks upregulated in the tongue cancer compared with healthy tongue tissue from the same patient. The canonical pathways ( Supplementary Fig. 1 ) involved in OSCC include calcium signalling, cell-to-cell interaction signalling, and immune system pathways involving phagocytes, amongst others.
Calcium signalling has a fundamental biological role, evolutionarily developed to be at the centre of almost all cellular processes, including signalling between cells, transcription, motility, innate immunity and apoptosis [37] . In cancer cells the calcium homeostasis is disrupted, as can be seen as the top canonical pathway involved. It is well established that calcium signalling alterations are implicated in tumour induction, angiogenesis, proliferation and metastasis [38] . Other examples of alterations are that, calcium-regulated membrane protein mutations, such as the IP3R (Inositol triphosphate receptor), have been detected in HNSCC [39] , and the PMCA1 (plasma membrane Ca2 + ATPase isoform 1) calcium transporter expression has been found to be downregulated in OSCC [38] . In our samples, a handful of calcium related proteins were upregulated, including but not limited to calreticulin, calponin 1 and 3, reticulocalbin, S100 proteins, which were upregulated, and calsequestrin was downregulated.
The network most enriched with the S-plot proteins, suggesting the most disrupted networks, was 'Cellular Movement, Haematological System Development and Function, Immune Cell Trafficking', linking in with the calcium signalling and other top canonical pathways. This network was almost completely enriched in S-plot proteins (Fig. 5) . It centres around NF-κB and MAPK (mitogen activated protein kinase), and contains multiple groups of proteins such as the S100s and the keratins amongst others. NF-κB plays a role in the regulation of various genes, including matrix metalloproteinases, anti-apoptotic factors, adhesion molecules, cytokines [40] . MAPKs are involved in the regulation of cell differentiation, proliferation and death in OSCC [41] .
In addition to their important role in mechanical stability and structural integrity of epithelial cells, keratins have additional functions including protection from stress, wound healing and apoptosis [42] . Expression of keratin isoforms differs in various cancers, reflecting tumour activity, and they thus have the potential to serve as prognostic markers as fragments of the cytokeratins have been demonstrated in the circulation. The cytokeratin detection tests known as TPA, which measures cytokeratins 8, 18 and 19 in the serum, and CYFRA-1, which measures soluble cytokeratin 18 fragments, have been documented in various epithelial cell related tumours including head and neck cancers [43] , as ways to monitor progression and response to treatment. KRT17 has been suggested as a diagnostic marker for OSCC and is highly Fig. 4 . Immunohistochemistry of S100A7, neutrophil defensin 1, and carbonic anhydrase 1. The top composite image shows immunohistochemical staining patterns using: anti-defensin 1 antibodies (first row of images); anti-S100A7 antibodies (second row of images); anti-carbonic anhydrase 1 antibodies (third row) in the tumour samples at 200x magnification. Control images are on the right-hand panel at 100x magnification to show the whole epithelial layer. The images were taken with a Nicon Eclipse 80i microscope. Below the composite image are the numbers and percentage of tumours with different staining intensities for each antibody, expressed in a tabular format. upregulated in the OSCC tissue on IHC [44] . In one study, KRT17 with low KRT13 was suggestive of malignant changes within oral lesions [45] , which correlates with our results of downregulated KRT13 (FC -6.19) and upregulated KRT17 (FC 1.98) in the tumour tissue.
Conclusions
We have shown that based on tissue proteomics, tongue cancer tissue samples can be separated from samples of healthy adjacent tissue. With an MS technique, we were able to identify a set of 35 upregulated and 37 downregulated statistically relevant proteins that most reliably represent this separation, many of which were novel in OSCC. These proteins were found to participate in processes including calcium signalling, epithelial integrity, neutrophil functioning, and cellular movement. There were some overlapping proteins compared to previous proteomic analysis however several novel proteins were detected, such as alpha-taxilin. Additionally, we show that KIAA1217 and NDRG1 are upregulated in stage IVa OSCC compared with stage I. We need further research to clarify whether the expression of some of these key proteins could serve as a potential biological classification component of different OSCC tumours.
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